Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole differently in duodenal ulcer patients and healthy volunteers
A. B. R. Thomson(University of Iowa), Paul Sinclair, L. ZUK, S. Appelman, M. Keelan(Alberta Hospital Edmonton), Kerstin Röhss(AstraZeneca (Sweden)), Roseann Lastiwka
Cited by 0
Related Papers
World Gastroenterology Organisation Global Guidelines
|Journal of Clinical Gastroenterology|2014|521
Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole
|Alimentary Pharmacology & Therapeutics|2001|175
Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects
|European Journal of Clinical Pharmacology|2000|140
Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole
|British Journal of Clinical Pharmacology|1998|124
Effect of Esomeprazole 40 mg vs Omeprazole 40 mg on 24-Hour Intragastric pH in Patients with Symptoms of Gastroesophageal Reflux Disease
|Digestive Diseases and Sciences|2002|93